Page 31 - JCBP-1-1
P. 31

Journal of Clinical and
            Basic Psychosomatics                                  Relationship between PD and melanoma based on NHANES



            were conducted, with constant adjustment for covariates   thus indicating an increased risk of melanoma in patients
            in the multivariate logistic regression analysis to assess   with PD.
            the relationship between PD and melanoma. Results were
            expressed as 95% confidence intervals (CI) and odds   3.3. Weighted multivariate logistic regression
            ratios  (OR)  of  p-values,  and  statistical  significance  was   Table 3 presents the results of three weighted multivariate
            determined at a two-tailed p < 0.05. Data sections in the   logistic regression models examining the association
            article were processed using R (http://www.R-project.org)   between PD and melanoma. After adjusting for covariates,
            and the “survey” package was utilized for data analysis.  PD  and melanoma  were  still  significantly correlated.
                                                               Model 1 did not adjust for any covariates, and the results of
            3. Results                                         model 1 showed that the risk of melanoma was 8.321-fold
            3.1. Participant characteristics                   greater in patients with PD than in the reference group,
                                                               using the non-PD group as a reference (OR, 8.321; 95%
            A total of 5822 subjects were included in the study,   CI, 1.007 – 68.787; p = 0.049). Model 2, after adjusting for
            comprising 48 melanoma patients and 5774 non-melanoma   age, gender, race, PIR, and BMI, revealed that patients in
            patients (Figure 1). All participants were aged 20 or over.   the PD group had 8.004-fold risk of developing melanoma
            Those in the melanoma group were generally older,   in comparison to the reference group (OR, 8.004; 95%
            had higher PIR scores, and were more likely to be non-  CI, 1.184 – 54.130; p  = 0.034). In addition, in model 3,
            Hispanic white than those in the non-melanoma group.
            The proportion of patients with PD in the melanoma   Table 1. Baseline characteristics of patients with melanoma
            group is significantly higher  than in the non-melanoma   and those non‑melanoma without melanoma
            group (2.45% vs. 0.30%). The differences in BMI, gender,
            smoking status, and number of moles between the two   Variable     Non‑melanoma    With    p‑value
            groups were not statistically significant (Table 1).              without melanoma  melanoma
                                                               Age               38.81 (0.28)  47.37 (1.12)  <0.0001
            3.2. Weighted univariate logistic regression analysis  PIR           3.04 (0.05)  3.66 (0.20)  0.003
            Table 2 shows the risk factors for melanoma in the weighted   BMI    28.08 (0.12)  27.68 (0.76)  0.6
            univariate logistic regression analysis. The results show   Gender                          0.76
            that age (OR, 1.08; 95% CI, 1.05 – 1.12), PIR (OR, 1.28;   Female   3051 (50.61)  22 (52.78)
            95% CI, 1.08 – 1.53), non-Hispanic whites (OR, 10.04; 95%
            CI, 2.05 – 49.30), and moles number of >10 (OR, 4.58; 95%   Male    2723 (49.39)  26 (47.22)
            CI, 1.07 – 19.59) were risk factors for melanoma. Moreover,   Race                          0.002
            our results also showed that individuals with PD had an   Black     1230 (11.80)  2 (1.54)
            8.32-fold increased risk of developing melanoma compared   White     1256 (8.77)  2 (1.58)
            to those without PD (OR,  8.32; 95% CI, 1.01 – 68.79),   Mexican     478 (10.07)  3 (6.26)
                                                                American
                                                                Other           2810 (69.36)  41 (90.62)
                                                               Smoking status                           0.23
                                                                Never           3075 (50.87)  23 (45.81)
                                                                Former          1097 (20.39)  12 (29.73)
                                                                Now             1602 (28.74)  13 (24.46)
                                                               Number of moles                          0.17
                                                                None            4296 (71.55)  29 (62.01)
                                                                1 or 2          1052 (19.25)  11 (21.20)
                                                                3 or 5           311 (6.60)   4 (8.64)
                                                                6 or 10          64 (1.40)    2 (3.36)
                                                                >10              51 (1.21)    2 (4.79)
                                                               PD                                       0.02
                                                                No              5752 (99.70)  47 (97.55)
                                                                Yes              22 (0.30)    1 (2.45)
            Figure 1. Flow diagram depicting the process of screening and enrolling   Abbreviations: BMI: Body mass index; PD: Parkinson’s disease;
            study participants.
                                                               PIR: Poverty income ratio.

            Volume 1 Issue 1 (2023)                         3                        https://doi.org/10.36922/jcbp.0571
   26   27   28   29   30   31   32   33   34   35   36